Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajem.2024.10.001 | DOI Listing |
Publication Analysis
Top Keywords
comments mis-c
4
mis-c treatment
4
treatment glucocorticoid
4
glucocorticoid monotherapy
4
monotherapy mild
4
mild cases?
4
comments
1
treatment
1
glucocorticoid
1
monotherapy
1
Similar Publications
The Importance of Differentiating MIS-C From Other Hyperinflammatory Conditions.
Pediatrics
December 2024
Endeavor Health Department of Pediatrics, Evanston, Illinois, Comer Children's Hospital, University of Chicago, Chicago, Illinois.
Comments on MIS-C treatment: Is glucocorticoid monotherapy enough for mild cases?
Am J Emerg Med
December 2024
George Washington University School of Medicine and Health Sciences, Washington, DC, United States.
More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
N Engl J Med
February 2024
Hospices Civils de Lyon, Lyon, France
More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
N Engl J Med
February 2024
University of California, San Diego, School of Medicine, La Jolla, CA
Continuing difficulties in distinguishing COVID-19 MIS-C from other disease entities.
Eur J Pediatr
December 2023
Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!